Blass_2000_Alzheimer.Dis.Assoc.Disord_14_39

Reference

Title : Randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and tolerability of metrifonate in patients with probable Alzheimer disease. The Metrifonate Study Group - Blass_2000_Alzheimer.Dis.Assoc.Disord_14_39
Author(s) : Blass JP , Cyrus PA , Bieber F , Gulanski B
Ref : Alzheimer Disease & Associated Disorders , 14 :39 , 2000
Abstract : Blass_2000_Alzheimer.Dis.Assoc.Disord_14_39
ESTHER : Blass_2000_Alzheimer.Dis.Assoc.Disord_14_39
PubMedSearch : Blass_2000_Alzheimer.Dis.Assoc.Disord_14_39
PubMedID: 10718203

Related information

Citations formats

Blass JP, Cyrus PA, Bieber F, Gulanski B (2000)
Randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and tolerability of metrifonate in patients with probable Alzheimer disease. The Metrifonate Study Group
Alzheimer Disease & Associated Disorders 14 :39

Blass JP, Cyrus PA, Bieber F, Gulanski B (2000)
Alzheimer Disease & Associated Disorders 14 :39